Akoustis Technologies Inc reports results for the quarter ended in June - Earnings Summary

Aktis Oncology

12/09/2022 14:31

* Akoustis Technologies Inc  AKTS.OQ  reported a quarterly
adjusted loss of 26 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 19 cents per share.
    * Revenue rose 141.2% to $5.20 million from a year ago;
analysts
expected $6.18 million. 
    * Akoustis Technologies Inc's reported EPS for the quarter
was a
loss of 28 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoustis Technologies Inc shares had risen by 19.7% this
quarter and lost 33.7% so far this year.
    * The company reported a quarterly loss of $16.27 million.
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data September
12 at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.19          -0.26          Missed
 Mar. 31 2022      -0.22          -0.22          Met
 Dec. 31 2021      -0.20          -0.23          Missed
 Sep. 30 2021      -0.20          -0.25          Missed